Sort By

MAP2K2 (MEK2) Recombinant Human Protein

MAP2K2 (MEK2) is a dual specificity serine⁄threonine kinase that is known to play a critical role in mitogen growth factor signal transduction.

MAP2K2 Monoclonal Antibody (OTI1A2), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western Blot, IF, ICC, IHC (P)

MAP2K2 Monoclonal Antibody (OTI5F6), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IHC (P), Flow

MAP2K2 Monoclonal Antibody (OTI5B4), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IF, ICC

MAP2K2 Monoclonal Antibody (OTI5G8), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IF, ICC

MAP2K2 Monoclonal Antibody (OTI5B4), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IF, ICC

MAP2K2 Monoclonal Antibody (OTI5G8), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IF, ICC

MAP2K2 Monoclonal Antibody (OTI1A2), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western Blot, IF, ICC, IHC (P)

MAP2K2 Monoclonal Antibody (OTI8G6), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IHC (P), Flow

MAP2K2 Monoclonal Antibody (OTI8G6), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IHC (P), Flow

MAP2K2 Monoclonal Antibody (OTI5F6), TrueMAB™ (OriGene)

MAP2K2 Monoclonal Antibody for Western blot, IHC (P), Flow

MEK2 Recombinant Rabbit Monoclonal Antibody (B19H36L8) (Invitrogen™)

MEK2 Recombinant Monoclonal Antibody for Western Blot, IF, ICC

PD98059 (Invitrogen™)

PD98059 is a potent and selective cell permeable inhibitor of MAP kinase kinase (MEK). It selectively blocks the activation of MEK, thereby inhibiting the phosphorylation and the activation of MAP kinase.

Format/Formulation: Lyophilized

CellSensor™ AP-1-bla ME-180 Cell Line

The CellSensor® AP-1-bla ME-180 Cell Line contains a beta-lactamase reporter gene under control of the AP-1 response element stably integrated into ME-180 cells. The cell line was created through FACS sorting of cells responsive to stimulation of the AP-1 pathway with Epidermal Growth Factor (EGF). This cell line was validated for DMSO tolerance, stimulant incubation time, substrate loading conditions, Z' and EC50 concentration of Epidermal Growth Factor. The AP-1-bla ME-180 Cell Line responds to agonist treatment as expected from the literature and can be adapted for high-throughput screening for agonists or antagonists of the AP-1 pathway with compound libraries. Candidate drugs can also be tested for dose response against this cell line. Academic and non-profit customers, please inquire for special pricing.

Phospho-MEK1/MEK2 (Ser217, Ser221) Polyclonal Antibody (Invitrogen™)

Phospho-MEK1/MEK2 (Ser217, Ser221) Polyclonal Antibody for Western Blot